Anna Marcinkowska

Anna Marcinkowska

Auto-generated profile, based on publicly available information

Anna Marcinkowska


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
JLJakub Lech
Jakub Lech
AMAnna Marcinkowska
Anna Marcinkowska
JNJulia Nowosielska
Julia Nowosielska
KSKarol Stobiński
Karol Stobiński
APAleksandra Płusa
Aleksandra Płusa
KLKatarzyna Latalska
Katarzyna Latalska
IntroductionPolycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by reproductive, metabolic, and inflammatory disturbances. Increasing evidence suggests that gut microbiota plays a significant role in the regulation of metabolic and neuroendocrine pathways involved in PCOS. AimThe aim of this review was to summarize current knowledge on the gut-brain-ovary axis in PCOS, with particular focus on the contribution of gut microbiota dysbiosis to metabolic inflammation and reproductive dysfunction. Material and methodsA narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Peer-reviewed articles published in English up to March 2024 were analyzed. Studies addressing associations, underlying mechanisms, and therapeutic interventions linking gut microbiota with metabolic, inflammatory, neuroendocrine, and reproductive features of PCOS were included. ResultsAvailable evidence indicates that women with PCOS exhibit significant alterations in gut microbiota composition, including reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and increased prevalence of pro-inflammatory taxa. These changes are associated with insulin resistance, impaired intestinal barrier function, metabolic endotoxemia, chronic low-grade inflammation, hyperandrogenism, and disturbances in hypothalamic-pituitary-ovarian signaling. ConclusionsGut microbiota dysbiosis appears to play an important integrative role in the pathophysiology of PCOS by linking metabolic inflammation with neuroendocrine and ovarian dysfunction. The gut-brain-ovary axis represents a promising conceptual framework and therapeutic target; however, further well-designed longitudinal and mechanistic studies are required.

14 July 2026 in Our Dermatology Online
Verified
Journal Article
Open access
SJSabina Maria Jóźwiak
Sabina Maria Jóźwiak
KPKarolina Pawelec
Karolina Pawelec
JJJakub Jagiełło
Jakub Jagiełło
AJAdam Jakubas
Adam Jakubas
KIKarolina Iwanicka
Karolina Iwanicka
SSSimone Szymczyk
Simone Szymczyk
Atopic dermatitis (AD) is a chronic, inflammatory skin disease that often begins in early childhood and significantly affects the quality of life of patients and their families. Conventional treatments include emollients, corticosteroids, and calcineurin inhibitors; however, these are often insufficient in moderate-to-severe cases. In recent years, novel targeted therapies, including biologics and Janus kinase (JAK) inhibitors, have shown promising clinical results in pediatric patients. Dupilumab and tralokinumab, monoclonal antibodies, have demonstrated significant improvement in AD symptoms, including reduction of pruritus and inflammation. JAK inhibitors, such as upadacitinib, abrocitinib, and baricitinib, modulate cytokine pathways involved in AD pathogenesis, leading to rapid and sustained improvement of skin lesions. These novel therapies exhibit favorable safety profiles and enable personalized approaches. This article reviews current evidence on the efficacy and safety of dupilumab, tralokinumab, and JAK inhibitors in the pediatric population, highlighting their role in modern AD management.

4 April 2026 in Quality in Sport
Verified
Journal Article
Open access
UZUrszula Zaluska
Urszula Zaluska
SSSimone Szymczyk
Simone Szymczyk
PBPatryk Barczuk
Patryk Barczuk
NPNatalia Pluta
Natalia Pluta
KSKarol Stobiński
Karol Stobiński
SJSabina Jóźwiak
Sabina Jóźwiak
The rapid development of wearable technologies has significantly influenced contemporary team sports by enabling advanced athlete monitoring and supporting data-driven training management. The aim of this systematic review was to evaluate the role of wearable technologies in team sports, with particular emphasis on training load monitoring, athlete performance analysis, and injury prevention. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, and studies were selected according to predefined inclusion and exclusion criteria. The analyzed literature indicates that wearable technologies, such as global positioning systems (GPS), inertial measurement units (IMU), accelerometers, and heart rate monitors, are widely used to assess both external and internal training load. These systems enable continuous data collection on movement patterns, physiological responses, and biomechanical demands during training and competition. As a result, they support workload evaluation, facilitate individualized training programs, and enhance evidence-based decision-making. Wearable technologies also contribute to injury prevention by enabling monitoring of cumulative load and sudden changes in training intensity, which may indicate increased injury risk. However, limitations remain, including issues related to measurement validity, inter-device variability, and challenges in data interpretation. In conclusion, wearable technologies represent valuable tools for improving athlete monitoring, optimizing training processes, and supporting injury prevention in team sports. Their effectiveness depends on both device accuracy and appropriate data interpretation. Further research is needed to standardize their application across different sports and performance levels.